Clinical Trial Update: Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. [NA]

View source ↗

Summary

This clinical trial update investigates whether the neutrophil-to-lymphocyte ratio (NLR) has prognostic value for patients with first-line metastatic or locally…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Breast Cancer, Metastatic Breast Cancer | NA | Status: COMPLETED